Fluxapyroxad

CAS : 907204-31-3

Ref. 3D-FF103006

Informations sur le produit

• Nom: Fluxapyroxad
• Synonymes: 1H-Pyrazole-4-carboxamide, 3-(difluoromethyl)-1-methyl-N-(3′,4′,5′-trifluoro[1,1′-biphenyl]-2-yl)-, 3-(Difluoromethyl)-1-methyl-N-(3′,4′,5′-trifluoro[1,1′-biphenyl]-2-yl)-1H-pyrazole-4-carboxamide, 3-(Difluoromethyl)-1-methyl-N-(3′,4′,5′-trifluorobiphenyl-2-yl)-1H-pyrazole-4-carboxamide, 3-(difluoromethyl)-1-methyl-N-(3',4',5'-trifluoro[1,1'-biphenyl]-2-yl)-1H-pyrazole-4-carboxamide, 3-(difluoromethyl)-1-methyl-N-(3',4',5'-trifluorobiphenyl-2-yl)pyrazole-4-carboxamide, Acceleron DX 612, Imbrex, Sercadis, Systiva XS, T5Nnj A1 Cyff Dvmr Br Cf Df Ef, Xemium, Xzemplar
• CAS: 907204-31-3

Description

Fluxapyroxad is a prothioconazole-based fungicide. It has a pyrazole ring and functions as an inhibitor of fungal cell wall synthesis by blocking the enzyme polyketide synthase. Fluxapyroxad also has a synergic effect with other fungicides and can be used in vitro to inhibit the growth of fungi that are resistant to other antifungal agents. The analytical method is based on fluorescence detection, which allows for sensitive detection at low concentrations. Fluxapyroxad is toxic to both animals and humans, but it has been shown to have little or no effect on bacteria. This product is not registered for use in the United States.br>br>Fluxapyroxad's primary mode of action is to inhibit fatty acid biosynthesis through competitive inhibition of 3-hydroxyacyl coenzyme A reductase (HACR). In addition, fluxapyroxad inhibits protein synthesis by binding to ribos

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 381.3 g/mol
• Formule: C₁₈H₁₂F₅N₃O
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C18H12F5N3O/c1-26-8-11(16(25-26)17(22)23)18(27)24-14-5-3-2-4-10(14)9-6-12(19)15(21)13(20)7-9/h2-8,17H,1H3,(H,24,27)
• Code InChI: InChIKey=SXSGXWCSHSVPGB-UHFFFAOYSA-N
• SMILES: Cn1cc(C(=O)Nc2ccccc2-c2cc(F)c(F)c(F)c2)c(C(F)F)n1